Brief ReportsEffectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis
References (7)
- et al.
Increased morbidity after coronary angioplasty in patients on chronic hemodialysis
Am J Cardiol
(1994) - et al.
Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients
Am Heart J
(1994) - et al.
Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients
Am Heart J
(1990)
Cited by (45)
Periprocedural Myocardial Infarction in Contemporary Practice
2019, Interventional Cardiology ClinicsCitation Excerpt :Predictors of periprocedural MI include factors related to the patient, lesion, and the procedure itself. Patients with advanced age, female gender, multivessel coronary artery disease (CAD), diffuse CAD, systemic atherosclerosis, diabetes mellitus, chronic and end-stage renal disease, and preprocedural cardiac biomarker elevation are at increased risk of periprocedural MI.3,11,18,66–68 Anatomic factors associated with an increased risk of periprocedural MI include lesions of the left main and left anterior descending arteries, bifurcation lesions, calcified lesions, lesions longer than 20 mm, advanced CAD (high Syntax score), complex lesions (American College of Cardiology/American Heart Association [ACC/AHA] type C), lesions with high thrombus burden, and saphenous vein graft (SVG) lesions.3,66,69
Myocardial revascularization in patients with chronic renal failure
2009, Medicina ClinicaCoronary artery disease and peripheral vascular disease in chronic kidney disease: An epidemiological perspective
2005, Cardiology ClinicsCitation Excerpt :The mortality risks of stent placement were also better than for PTCA; however; this benefit was mainly confined to nondiabetics. These findings have confirmed and have extended the observations of several other groups in demonstrating the benefit of CABG over PTCA and stent placement, at least in observational studies [84–89]. The question of confounding by selection bias will always remain, because patients who undergo CABG are likely to have more severe disease and to have higher overall cardiovascular risk than those treated with PTCA.
Coronary revascularization in patients with coronary artery disease and chronic kidney disease
2004, Advances in Chronic Kidney DiseaseAnalysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes
2003, American Journal of CardiologyCitation Excerpt :Patients who underwent coronary angiography and were subsequently treated with medical therapy had better long-term survival compared with those treated with medical therapy alone (p <0.0001). Previous studies have clearly established that the outcomes of surgical and percutaneous coronary revascularization are worse in patients with CKD compared with patients with normal renal function.3–13 It is also widely accepted that patients with CKD presenting with ACS have worse outcomes compared with those with normal renal function.14–19